The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
The Children's Oncology Group (COG), a clinical trials group supported by the National Cancer Institute (NCI), is the world's largest organization devoted exclusively to pediatric cancer research. The COG conducts a spectrum of clinical research and translational research trials for infants, children, adolescents, and young adults with cancer.
The Eppley Institute for Research in Cancer and Allied Diseases is a research institute at the University of Nebraska Medical Center in Omaha, Nebraska, United States.
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is a National Cancer Institute (NCI)-designated comprehensive cancer center located in Baltimore, Maryland.
John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.
Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.
The Binaytara Foundation (BTF) was established in 2007 by Dr. Binay Shah and wife Tara Shah with the goal of promoting health and education in underprivileged societies. The BTF is a Washington State nonprofit organization exempt from taxation pursuant to Section 501(c)(3) of the Internal Revenue Code. BTF has founded multiple programs in underdeveloped and developing countries to improve access to healthcare. Recent accomplishments include building a 25-bed cancer hospital in Nepal in 2018 and breaking ground on their new 200-bed facility in 2022.
William G. Nelson is the Marion I. Knott Professor of Oncology, Urology, Pharmacology, Pathology, and Medicine at the Johns Hopkins School of Medicine. He earned his B.A. in Chemistry from Yale University in 1980 and his M.D. and Ph.D. in Pharmacology from Johns Hopkins School of Medicine in 1987. His research is focused on cancer epigenetics and on new strategies for prostate cancer and prevention. He serves on the boards of the V Foundation, the Break Through Cancer Foundation, and Armis Biopharma, and on the scientific advisory boards of the Prostate Cancer Foundation, Stand Up to Cancer, and Cepheid. He was appointed as the Director of the Sidney Kimmel Comprehensive Cancer Center in 2008.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
The OHSU Knight Cancer Institute is a research institute within Oregon Health & Science University. The National Cancer Institute (NCI) designated cancer center is led by director Brian Druker. It is the only NCI-designated Comprehensive Cancer Center in the state of Oregon. The institute is named after Phil Knight and his wife, who donated over $600 million to the center; $100 million in 2008 and $500 million in 2013. The $500 million gift required a matching $500 million, which led to a $100 million donation by Columbia Sportswear chairwoman Gert Boyle in 2014.
The Mayo Clinic Cancer Center (MCCC) is a National Cancer Institute (NCI)-designated Cancer Center and a division of the Mayo Clinic. The MCCC has 3 locations in the United States: Phoenix, Arizona, Jacksonville, Florida, and Rochester, Minnesota.
The Rebecca and John Moores Cancer Center is the region's only NCI-designated Cancer Center in La Jolla, California, part of UC San Diego Health and affiliated with the University of California San Diego. It is supported, in part, by the National Cancer Institute.
Ashani Tanuja Weeraratna is a Sri Lanka-born American cancer researcher whose findings are contributing to the scientific understanding of melanoma tumors. She is a Bloomberg Distinguished Professor of cancer biology and the E.V. McCollum Professor and Chair of the department of biochemistry and molecular biology at the Johns Hopkins Bloomberg School of Public Health. Weeraratna is a member of the National Cancer Advisory Board, which advises and assists the director of the National Cancer Institute on the activities of the national cancer program.
Mary Armanios is Professor of Oncology, Genetic Medicine, Pathology and Molecular Biology, and Genetics at Johns Hopkins University School of Medicine and the Director of the Telomere Center at Johns Hopkins University. Her research focuses on the role of telomeres in disease.
Karen E. Knudsen is Chief Executive Officer of American Cancer Society and its advocacy affiliate the American Cancer Society Cancer Action Network. She is the first woman to hold that position in either organization.
Nirali N. Shah is an American physician-scientist and pediatric hematologist-oncologist, serving as head of the hematologic malignancies section of the pediatric oncology branch at the National Cancer Institute. She researches the translation of immunotherapeutic approaches to treat high-risk hematologic malignancies in children, adolescents and young adults.
Suzanne Louise Topalian is an American surgical oncologist. She is the Bloomberg-Kimmel Professor of Cancer Immunotherapy in the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University School of Medicine. In this role, she studies human anti-tumor immunity.
Andrew Mark Pardoll is Director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy and Abeloff Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics at Johns Hopkins University, School of Medicine. He is also Director of the Cancer Immunology Program at the Sidney Kimmel Comprehensive Cancer Center.
Nilofer Saba Azad is an American oncologist and physician-scientist specialized in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She is a professor at the Johns Hopkins School of Medicine and oversees clinical trials at the Sidney Kimmel Comprehensive Cancer Center.
Julie Renee Brahmer is an American thoracic oncologist. She is the co-director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University and the Marilyn Meyerhoff Professor in Thoracic Oncology.
